Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains
- PMID: 8798468
- DOI: 10.1074/jbc.271.37.22885
Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains
Abstract
The urokinase plasminogen activator receptor (uPAR) is a membrane protein comprised of three extracellular domains. In order to study the importance of this domain organization in the ligand-binding process of the receptor we subjected a recombinant, soluble uPAR (suPAR) to specific proteolytic cleavages leading to liberation of single domains. Treatment of the receptor with pepsin resulted in cleavage between residues 183 and 184, thus separating the third domain (D3) from the rest of the molecule, which was left as an intact fragment (D(1 + 2)). D(1 + 2) proved capable of ligand binding as shown by chemical cross-linking, but quantitative binding/competition studies showed that the apparent ligand affinity was 100- to 1000-fold lower than that of the intact suPAR. This loss of affinity was comparable with the loss found after cleavage between the first domain (D1) and D(2 + 3), using chymotrypsin. This result shows that in addition to D1, which has an established function in ligand binding (Behrendt, N., Ploug, M., Patthy, L., Houen, G., Blasi, F., and Dano, K. (1991) J. Biol. Chem. 266, 7842-7847), D3 has an important role in governing a high affinity in the intact receptor. Real-time biomolecular interaction analysis revealed that the decrease in affinity was caused mostly by an increased dissociation rate of the ligand complex of D(1 + 2). Zero length cross-linking, using carbodiimide-induced, direct condensation, was used to identify regions within suPAR engaged in molecular ligand contact. The purified suPAR was cross-linked to the radiolabeled amino-terminal fragment (ATF) of urokinase, followed by cleavage with chymotrypsin. In accordance with the cleavage pattern found for the uncomplexed receptor, this treatment led to cleavage between D1 and D(2 + 3). Analysis of the radiolabeled fragments revealed the expected ligand labeling of D1 but a clear labeling of D(2 + 3) was also found, indicating that this part of the molecule is also situated in close contact with ATF in the receptor-ligand complex. The latter contact site may contribute to the role of molecular regions outside D1 in high affinity binding.
Similar articles
-
Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.Biochem J. 2001 Sep 15;358(Pt 3):673-9. doi: 10.1042/0264-6021:3580673. Biochem J. 2001. PMID: 11535128 Free PMC article.
-
Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.Biochemistry. 1998 Nov 24;37(47):16494-505. doi: 10.1021/bi981203r. Biochemistry. 1998. PMID: 9843416
-
Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells.J Biol Chem. 1998 May 29;273(22):13933-43. doi: 10.1074/jbc.273.22.13933. J Biol Chem. 1998. PMID: 9593742
-
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8808830 Review. Japanese.
-
Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.Biochem Soc Trans. 2002 Apr;30(2):177-83. Biochem Soc Trans. 2002. PMID: 12023847 Review.
Cited by
-
Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.Biochem J. 2001 Sep 15;358(Pt 3):673-9. doi: 10.1042/0264-6021:3580673. Biochem J. 2001. PMID: 11535128 Free PMC article.
-
uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion.J Cell Biol. 2003 Mar 31;160(7):1009-15. doi: 10.1083/jcb.200211091. J Cell Biol. 2003. PMID: 12668656 Free PMC article.
-
suPAR, a Circulating Kidney Disease Factor.Front Med (Lausanne). 2021 Oct 6;8:745838. doi: 10.3389/fmed.2021.745838. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34692736 Free PMC article. Review.
-
Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.PLoS One. 2014 Aug 26;9(8):e105929. doi: 10.1371/journal.pone.0105929. eCollection 2014. PLoS One. 2014. PMID: 25157856 Free PMC article.
-
The collagen receptor uPARAP/Endo180 regulates collectins through unique structural elements in its FNII domain.J Biol Chem. 2020 Jul 3;295(27):9157-9170. doi: 10.1074/jbc.RA120.013710. Epub 2020 May 18. J Biol Chem. 2020. PMID: 32424040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources